Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. MSFT
10. IBM

Go back to Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa (KNSA) PT Raised to $35 at Evercore ISI

October 29, 2024 4:23 PM EDT

Evercore ISI analyst Liisa Bayko raised the price target on Kiniksa (NASDAQ: KNSA) to $35.00 (from $30.00) while maintaining a Outperform rating.

The analyst comments "KNSA has a solid Q with $112.2M Arcalyst sales slightly beating consensus of $111.5M. KNSA raised... More